Accessibility Menu
VanEck ETF Trust - VanEck Biotech ETF logo

VanEck ETF Trust - VanEck Biotech ETF(NASDAQ) BBH

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+546%
5 Year+4%
1 Year+38%
1 Month+3%
$213.98
+1.57%
+3.31Today
VanEck ETF Trust - VanEck Biotech ETF last closing stock price
MetricPriceDate
Last closeUSD 216.582026-08-07
VanEck ETF Trust - VanEck Biotech ETF stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.37%USD 205.552026-07-31
1 month+3.49%USD 209.282026-07-08
3 month+17.33%USD 184.602026-05-08
Year to date+14.43%USD 189.262025-12-31
1 year+38.21%USD 156.712025-08-07
3 year+37.13%USD 157.932023-08-08
5 year+3.51%USD 209.232021-08-06
Since inception+546.06%USD 33.522011-12-21

VanEck ETF Trust - VanEck Biotech ETF Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.96

Beta (Volatility)

0.80 (Low)

Price

$213.98

Volume

5,179

Open

$213.36

Previous Close

$216.58

Daily Range

$212.81 - $216.58

52-Week Range

$158.78 - $216.58

Estimated Earnings Date

N/A

About VanEck ETF Trust - VanEck Biotech ETF

The VanEck Biotech ETF focuses on reflecting the performance of the MVIS US Listed Biotech 25 Index. This ETF provides exposure to companies engaged in biotechnology, including research, manufacturing, and sales of biotech products.

Products and Services
  • Tracks the MVIS US Listed Biotech 25 Index
  • Invests in biotechnology companies
  • Offers potential for capital appreciation and income yield
Growth Outlook
  • Biotech sector expected to grow due to increasing healthcare demands
  • Advancements in genetic research driving innovation and investment
  • Market capitalization of biotech companies continues to rise
Financial Highlights
  • Current price stands at $201.15, reflecting strong market interest
  • Dividend yield of 0.48% offers income potential
  • 52-week price range between $156.45 and $212.54 indicates stability
AI Generated • Jul 23, 2026

Industry

Capital Markets

Headquarters

New York, NY 10017, US

BBH Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.44%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.95M

Volume

5.18K

Avg. Volume

5.06K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

VanEck ETF Trust - VanEck Biotech ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FEPFirst Trust Europe AlphaDEX Fund
$60.03+0.59%
QMOMAlpha Architect U.S. Quantitative Momentum ETF
$77.10+1.88%
FADFirst Trust Multi Cap Growth AlphaDEX Fund
$191.69+1.29%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$133.11+0.16%
TTDThe Trade Desk
$13.80-0.22%
NVDANvidia
$223.96+0.02%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$82.76+0.00%

Questions About BBH

What is the current price of VanEck ETF Trust - VanEck Biotech ETF?

VanEck ETF Trust - VanEck Biotech ETF is trading at $216.58 per share.

What is the 52-week range for VanEck ETF Trust - VanEck Biotech ETF?

Over the past 52 weeks, VanEck ETF Trust - VanEck Biotech ETF has traded between $158.78 and $216.58.

How much debt does VanEck ETF Trust - VanEck Biotech ETF have?

VanEck ETF Trust - VanEck Biotech ETF total debt is unavailable.

How much cash does VanEck ETF Trust - VanEck Biotech ETF have on hand?

VanEck ETF Trust - VanEck Biotech ETF does not have cash on hand data available.

What is VanEck ETF Trust - VanEck Biotech ETF’s dividend yield?

VanEck ETF Trust - VanEck Biotech ETF currently has a dividend yield of 0.44%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.